---
title: "Bank of America Securities Keeps Their Sell Rating on Amphastar Pharmaceuticals (AMPH)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295385382.md"
description: "Bank of America Securities analyst Jason Gerberry reiterated a Sell rating on Amphastar Pharmaceuticals (AMPH) with a $20.00 price target, noting the stock closed at $20.78. This contrasts with the broader market consensus, which rates AMPH as a Hold with an average target of $21.67. Gerberry, a top-rated healthcare analyst, maintains his bearish stance despite the company's recent trading levels."
datetime: "2026-08-10T09:26:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295385382.md)
  - [en](https://longbridge.com/en/news/295385382.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295385382.md)
generator: "portal-rs"
---

# Bank of America Securities Keeps Their Sell Rating on Amphastar Pharmaceuticals (AMPH)

In a report released on August 7, Jason Gerberry from Bank of America Securities reiterated a Sell rating on Amphastar Pharmaceuticals, with a price target of $20.00. The company’s shares closed last Friday at $20.78.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Gerberry is a 5-star analyst with an average return of 21.5% and a 62.99% success rate. Gerberry covers the Healthcare sector, focusing on stocks such as Merck & Company, Bristol-Myers Squibb, and Ionis Pharmaceuticals.

Currently, the analyst consensus on Amphastar Pharmaceuticals is a Hold with an average price target of $21.67.

### Related Stocks

- [AMPH.US](https://longbridge.com/en/quote/AMPH.US.md)
- [BAC.US](https://longbridge.com/en/quote/BAC.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)
- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [IONS.US](https://longbridge.com/en/quote/IONS.US.md)
- [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md)
- [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md)
- [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md)
- [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md)
- [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md)
- [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md)
- [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md)
- [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md)
- [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md)
- [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md)
- [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md)
- [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md)
- [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md)
- [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md)
- [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md)
- [8648.JP](https://longbridge.com/en/quote/8648.JP.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)

## Related News & Research

- [Amphastar CFO William J. Peters melepas saham biasa senilai $183.826,4](https://longbridge.com/en/news/295579594.md)
- [Amphastar Pharmaceuticals subsidiary receives FDA warning letter over CGMP issues at California facility](https://longbridge.com/en/news/292050282.md)
- [Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Lower Q2 Expenses, Advances Lucid-MS Into Phase 2](https://longbridge.com/en/news/296129489.md)
- [REG - Threadneedle AM Hdgs SEGRO PLC Prologis, Inc. - Form 8.3 Segro Plc](https://longbridge.com/en/news/296629732.md)
- [Ocular Therapeutix Earns Buy Rating as Axpaxli Differentiation and LUGANO TKI Data Bolster Confidence in Lead Asset](https://longbridge.com/en/news/296129081.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**